Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Brain Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)Study completedNCT01904123
What this trial is testing

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaRecurrent Brain Neoplasm+2 more
M.D. Anderson Cancer Center 8
Early research (Phase 1)Study completedNCT00416923
What this trial is testing

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Not applicableStudy completedNCT00255671
What this trial is testing

Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity
Case Comprehensive Cancer Center 76
Testing effectiveness (Phase 2)Study completedNCT00462982
What this trial is testing

Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer
Memorial Sloan Kettering Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Not applicableUnknownNCT05868928
What this trial is testing

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Who this might be right for
Brain MetastasesRadiosurgery
Asan Medical Center 132
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT00280748
What this trial is testing

Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT01898130
What this trial is testing

Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751744
What this trial is testing

Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma

Who this might be right for
Brain Metastases From Solid TumorsLeptomeningeal DiseaseHigh Grade Glioma (HGG)+1 more
Jubilant Therapeutics Inc. 113
Not applicableLooking for participantsNCT04427384
What this trial is testing

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Who this might be right for
Brain Tumor, RecurrentBrain TumorBrain Tumor, Primary+3 more
GT Medical Technologies, Inc. 600
Very early researchLooking for participantsNCT07268053
What this trial is testing

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Who this might be right for
Glioblastoma (GBM)Brain Metastasases
Nader Sanai 15
Early research (Phase 1)Study completedNCT00784914
What this trial is testing

A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
City of Hope Medical Center 12
Early research (Phase 1)Ended earlyNCT00253721
What this trial is testing

Melphalan With BBBD in Treating Patients With Brain Malignancies

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
OHSU Knight Cancer Institute 21
Testing effectiveness (Phase 2)Study completedNCT00814021
What this trial is testing

Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain

Who this might be right for
Kidney CancerMetastatic Cancer
Institut Claudius Regaud 21
Not applicableEnded earlyNCT02433171
What this trial is testing

Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery

Who this might be right for
Brain Metastasis
Yale University 8
Testing effectiveness (Phase 2)Ended earlyNCT00554775
What this trial is testing

WBRT & Erlotinib in Advanced NSCLC and Brain Metastases

Who this might be right for
Lung CancerMetastatic Cancer
University College, London 80
Early research (Phase 1)Study completedNCT00003712
What this trial is testing

CCI-779 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
The University of Texas Health Science Center at San Antonio 15
Next Page